Schistosomiasis does not affect the outcome of HCV infection in genotype 4-infected patients

American Journal of Tropical Medicine and Hygiene

Volumn 90, Issue 5, 2014, Pages 823-829

  Allam, Walaa R ^a   Barakat, Ahmed ^b   Zakaria, Zainab ^a   Galal, Gehan ^a   Abdel Ghafar, Tamer S ^c   El Tabbakh, Mohamed ^c   Mikhail, Nabiel ^d   Waked, Imam ^c   Abdelwahab, Sayed F ^e  

^a Egyptian Company for Blood Transfusion Services (EgyBlood)   (Egypt)

^b Ain Shams University   (Egypt)

^c MENOUFIA UNIVERSITY   (Egypt)

^d ASSIUT UNIVERSITY   (Egypt)

^e Minia University   (Egypt)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON;

ABDOMINAL RADIOGRAPHY; ADULT; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; ECHOGRAPHY; ENZYME IMMUNOASSAY; ENZYME LINKED IMMUNOSPOT ASSAY; FEMALE; HEALTH CARE PERSONNEL; HEALTH SURVEY; HEPATITIS C; HEPATITIS C VIRUS GENOTYPE 4; HUMAN; INCIDENCE; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; MIXED INFECTION; OUTCOME ASSESSMENT; PERIPHERAL BLOOD MONONUCLEAR CELL; PREVALENCE; SCHISTOSOMA MANSONI; SCHISTOSOMIASIS; VIRAL CLEARANCE; VIRUS LOAD; VIRUS STRAIN;

ADULT; ANIMALS; ANTIGENS, VIRAL; COINFECTION; CROSS-SECTIONAL STUDIES; EGYPT; FEMALE; GENOTYPE; HEPACIVIRUS; HEPATITIS C; HUMANS; IMMUNITY, CELLULAR; INTERFERON-GAMMA; LEUKOCYTES, MONONUCLEAR; LIVER; MALE; MIDDLE AGED; SCHISTOSOMA MANSONI; SCHISTOSOMIASIS; VIRAL LOAD; VIREMIA;

EID: 84900400584     PISSN: 00029637     EISSN: None     Source Type: Journal    
DOI: 10.4269/ajtmh.13-0703     Document Type: Article

References (45)

1. Lauer GM, Walker BD, 2001. Hepatitis C virus infection. N Engl J Med 345: 41-52. (Pubitemid 32634271)
2. Liang TJ, Rehermann B, Seeff LB, Hoofnagle JH, 2000. Pathogenesis, natural history, treatment and prevention of hepatitis C. Ann Intern Med 132: 296.
3. Seeff LB, 1998. The natural history of hepatitis C-A quandary. Hepatology 28: 1710-1712. (Pubitemid 28549146)
4. Guerra J, Garenne M, Mohamed MK, Fontanet A, 2012. HCV burden of infection in Egypt: results from a nationwide survey. J Viral Hepat 19: 560-567.
5. Ryder SD, Irving WL, Jones DA, Neal KR, Underwood JC, 2004. Progression of hepatic fibrosis in patients with hepatitis C: a prospective repeat liver biopsy study. Gut 53: 451-455. (Pubitemid 38241346)
6. Missiha SB, Ostrowski M, Heathcote EJ, 2008. Disease progression in chronic hepatitis C: modifiable and nonmodifiable factors. Gastroenterology 134: 1699-1714. (Pubitemid 351615412)
7. Thomas DL, Astemborski J, Rai RM, Anania FA, Schaeffer M, Galai N, Nolt K, Nelson KE, Strathdee SA, Johnson L, Laeyendecker O, Boitnott J, Wilson LE, Vlahov D, 2000. The natural history of hepatitis C virus infection: host, viral and environmental factors. JAMA 284: 450-456. (Pubitemid 30484478)
8. Blanton RE, Salam EA, Kariuki HC, Magak P, Silva LK, Muchiri EM, Thiongo F, Abdel-Meghid IE, Butterworth AE, Reis MG, Ouma JH, 2002. Population-based differences in Schistosoma mansoni- and hepatitis C-induced disease. J Infect Dis 185: 1644-1649. (Pubitemid 34587527)
9. Angelico M, Renganathan E, Gandin C, Fathy M, Profili MC, Refai W, De Santis A, Nagi A, Amin G, Capocaccia L, Callea F, Rapicetta M, Badr G, Rocchi G, 1997. Chronic liver disease in the Alexandria governorate, Egypt: contribution of schistosomiasis and hepatitis virus infections. J Hepatol 26: 236-243. (Pubitemid 27077419)
10. El-Awady MK, Youssef SS, Omran MH, Tabll AA, El Garf WT, Salem AM, 2006. Soluble egg antigen of Schistosoma haematobium induces HCV replication in PBMC from patients with chronic HCV infection. BMC Infect Dis 6: 91.
11. Kamal S, Madwar M, Bianchi L, Tawil AE, Fawzy R, Peters T, Rasenack JW, 2000. Clinical, virological and histopathological features: long-term follow-up in patients with chronic hepatitis C co-infected with S. mansoni. Liver 20: 281-289. (Pubitemid 30488534)
12. Iida F, Iida R, Kamijo H, Takaso K, Miyazaki Y, Funabashi W, Tsuchiya K, Matsumoto Y, 1999. Chronic Japanese schistosomiasis and hepatocellular carcinoma: ten years of follow-up in Yamanashi Prefecture, Japan. Bull World Health Organ 77: 573-581. (Pubitemid 29352538)
13. Hassan MM, Zaghloul AS, El-Serag HB, Soliman O, Patt YZ, Chappell CL, Beasley RP, Hwang LY, 2001. The role of hepatitis C in hepatocellular carcinoma: a case control study among Egyptian patients. J Clin Gastroenterol 33: 123-126. (Pubitemid 32685921)
14. Barria MI, Vera-Otarola J, Leon U, Vollrath V, Marsac D, Riquelme A, Lopez-Lastra M, Soza A, 2008. Influence of extrahepatic viral infection on the natural history of hepatitis C. Ann Hepatol 7: 136-143. (Pubitemid 351845524)
15. Derbala M, Amer A, 2009. Hepatocellular carcinoma in Hepatitis C genotype 4 after viral clearance and in absence of cirrhosis: two case reports. Cases J 2: 7927.
16. el-Shazly Y, Abdel-Salam AF, Abdel-Ghaffar A, Mohran Z, Saleh SM, 1994. Schistosomiasis as an important determining factor for the response of Egyptian patients with chronic hepatitis C to therapy with recombinant human alpha-2 interferon. Trans R Soc Trop Med Hyg 88: 229-231. (Pubitemid 24139700)
17. Kamal SM, Madwar MA, Peters T, Fawzy R, Rasenack J, 2000. Interferon therapy in patients with chronic hepatitis C and schistosomiasis. J Hepatol 32: 172-174. (Pubitemid 30039465)
18. Kamal SM, El Tawil AA, Nakano T, He Q, Rasenack J, Hakam SA, Saleh WA, Ismail A, Aziz AA, Madwar MA, 2005. Peginterferon {alpha}-2b and ribavirin therapy in chronic hepatitis C genotype 4: impact of treatment duration and viral kinetics on sustained virological response. Gut 54: 858-866. (Pubitemid 40732106)
19. Pearce EJ, MacDonald AS, 2002. The immunobiology of schistosomiasis. Nat Rev Immunol 2: 499-511. (Pubitemid 37328741)
20. Cerny A, Chisari FV, 1999. Pathogenesis of chronic hepatitis C: immunological features of hepatic injury and viral persistence. Hepatology 30: 595-601. (Pubitemid 29409400)
21. Kamal SM, Rasenack JW, Bianchi L, Al Tawil A, El Sayed Khalifa K, Peter T, Mansour H, Ezzat W, Koziel M, 2001. Acute hepatitis C without and with schistosomiasis: correlation with hepatitis C-specific CD4(+) T-cell and cytokine response. Gastroenterology 121: 646-656. (Pubitemid 32822580)
22. Gerlach JT, Diepolder HM, Jung MC, Gruener NH, Schraut WW, Zachoval R, Hoffmann R, Schirren CA, Santantonio T, Pape GR, 1999. Recurrence of hepatitis C virus after loss of virus-specific CD4(+) T-cell response in acute hepatitis C. Gastroenterology 117: 933-941. (Pubitemid 29468237)
23. Rehermann B, 1999. Cellular immune response to the hepatitis C virus. J Viral Hepat 6 (Suppl 1): 31-35. (Pubitemid 29349786)
24. Lechner F, Wong DK, Dunbar PR, Chapman R, Chung RT, Dohrenwend P, Robbins G, Phillips R, Klenerman P, Walker BD, 2000. Analysis of successful immune responses in persons infected with hepatitis C virus. J Exp Med 191: 1499-1512. (Pubitemid 30257347)
25. Thimme R, Oldach D, Chang KM, Steiger C, Ray SC, Chisari FV, 2001. Determinants of viral clearance and persistence during acute hepatitis C virus infection. J Exp Med 194: 1395-1406. (Pubitemid 33081515)
26. Kamal SM, Bianchi L, Al Tawil A, Koziel M, El Sayed Khalifa K, Peter T, Rasenack JW, 2001. Specific cellular immune response and cytokine patterns in patients coinfected with hepatitis C virus and Schistosoma mansoni. J Infect Dis 184: 972-982. (Pubitemid 32955113)
27. Ezenwa VO, Jolles AE, 2011. From host immunity to pathogen invasion: the effects of helminth coinfection on the dynamics of microparasites. Integr Comp Biol 51: 540-551.
28. Abdelwahab S, Rewisha E, Hashem M, Sobhy M, Galal I, Allam WR, Mikhail N, Galal G, El-Tabbakh M, El-Kamary SS, Waked I, Strickland GT, 2012. Risk factors for hepatitis C virus infection among Egyptian healthcare workers in a national liver diseases referral centre. Trans R Soc Trop Med Hyg 106: 98-103.
29. Abdelwahab SF, Hashem M, Galal I, Sobhy M, Abdel-Ghaffar TS, Galal G, Mikhail N, El-Kamary SS, Waked I, Strickland GT, 2013. Incidence of hepatitis C virus infection among Egyptian healthcare workers at high risk of infection. J Clin Virol 57: 24-28.
30. McOmish F, Yap PL, Dow BC, Follett EA, Seed C, Keller AJ, Cobain TJ, Krusius T, Kolho E, Naukkarinen R, Lin C, Lai C, Leong S, Medgyesi GA, Hejjas M, Kiyokawa H, Fukada K, Cuypers T, Saeed AA, Al-Rasheed AM, Lin M, Simmonds P, 1994. Geographical distribution of hepatitis C virus genotypes in blood donors: an international collaborative survey. J Clin Microbiol 32: 884-892. (Pubitemid 24100056)
31. Ohno O, Mizokami M, Wu RR, Saleh MG, Ohba K, Orito E, Mukaide M, Williams R, Lau JY, 1997. New hepatitis C virus (HCV) genotyping system that allows for identification of HCV genotypes 1a, 1b, 2a, 2b, 3a, 3b, 4, 5a, and 6a. J Clin Microbiol 35: 201-207. (Pubitemid 26422655)
32. Abdelwahab SF, Zakaria Z, Sobhy M, Rewisha E, Mahmoud MA, Amer MA, Del Sorbo M, Capone S, Nicosia A, Folgori A, Hashem M, El-Kamary SS, 2012. Hepatitis C virus-multispecific T-cell responses without viremia or seroconversion among Egyptian health care workers at high risk of infection. Clin Vaccine Immunol 19: 780-786.
33. Al-Sherbiny M, Osman A, Mohamed N, Shata MT, Abdel-Aziz F, Abdel-Hamid M, Abdelwahab SF, Mikhail N, Stoszek S, Ruggeri L, Folgori A, Nicosia A, Prince AM, Strickland GT, 2005. Exposure to hepatitis C virus induces cellular immune responses without detectable viremia or seroconversion. Am J Trop Med Hyg 73: 44-49. (Pubitemid 41278744)
34. Abdel-Aziz F, Habib M, Mohamed MK, Abdel-Hamid M, Gamil F, Madkour S, Mikhail NN, Thomas D, Fix AD, Strickland GT, Anwar W, Sallam I, 2000. Hepatitis C virus (HCV) infection in a community in the Nile Delta: population description and HCV prevalence. Hepatology 32: 111-115. (Pubitemid 30432374)
35. Strickland GT, Elhefni H, Salman T, Waked I, Abdel-Hamid M, Mikhail NN, Esmat G, Fix A, 2002. Role of hepatitis C infection in chronic liver disease in Egypt. Am J Trop Med Hyg 67: 436-442. (Pubitemid 35303870)
36. Kamal SM, Madwar MA, Peters T, Fawzy R, Rasenack J, 2000. Interferon therapy in patients with chronic hepatitis C and schistosomiasis. J Hepatol 32: 172-174. (Pubitemid 30039465)
37. Pearce EJ, Caspar P, Grzych JM, Lewis FA, Sher A, 1991. Down-regulation of Th1 cytokine production accompanies induction of Th2 responses by a parasitic helminth, Schistosoma mansoni. J Exp Med 173: 159-166.
38. Cheever AW, Jankovic D, Yap GS, Kullberg MC, Sher A, Wynn TA, 1998. Role of cytokines in the formation and downregulation of hepatic circumoval granulomas and hepatic fibrosis in Schistosoma mansoni-infected mice. Mem Inst Oswaldo Cruz 93 (Suppl 1): 25-32.
39. King CL, Medhat A, Malhotra I, Nafeh M, Helmy A, Khaudary J, Ibrahim S, El-Sherbiny M, Zaky S, Stupi RJ, Brustoski K, Shehata M, Shata MT, 1996. Cytokine control of parasite-specific anergy in human urinary schistosomiasis. IL-10 modulates lymphocyte reactivity. J Immunol 156: 4715-4721. (Pubitemid 26174455)
40. Scott JT, Turner CM, Mutapi F, Woolhouse ME, Ndhlovu PD, Hagan P, 2001. Cytokine responses to mitogen and Schistosoma haematobium antigens are different in children with distinct infection histories. Parasite Immunol 23: 519-526. (Pubitemid 32989536)
41. Derbala MF, Amer AM, Almohanadi M, John A, Amin A, Sharma M, Alkaabi SR, Al Dweik NZ, Pasic F, Yaqoob R, Butt MT, Shebl FM, 2011. Hepatitis C virus genotype 4 with normal transaminases: histological changes, schistosomiasis and response to treatment. J Viral Hepat 18: e258-e262.
42. Farid A, Al-Sherbiny M, Osman A, Mohamed N, Saad A, Shata MT, Lee DH, Prince AM, Strickland GT, 2005. Schistosoma infection inhibits cellular immune responses to core HCV peptides. Parasite Immunol 27: 189-196. (Pubitemid 40961261)
43. Elrefaei M, El-sheikh N, Kamal K, Cao H, 2004. Analysis of T cell responses against hepatitis C virus genotype 4 in Egypt. J Hepatol 40: 313-318. (Pubitemid 38115838)
44. Kamal SM,GrahamCS,HeQ, Bianchi L, TawilAA, Rasenack JW, Khalifa KA, Massoud MM, Koziel MJ, 2004. Kinetics of intrahepatic hepatitis C virus (HCV)-specific CD4+ T cell responses in HCV and Schistosoma mansoni coinfection: relation to progression of liver fibrosis. J Infect Dis 189: 1140-1150. (Pubitemid 38457236)
45. Kamal SM, Turner B, He Q, Rasenack J, Bianchi L, Al Tawil A, Nooman A, Massoud M, Koziel MJ, Afdhal NH, 2006. Progression of fibrosis in hepatitis C with and without schistosomiasis: correlation with serum markers of fibrosis. Hepatology 43: 771-779.